NCT02944799View on ClinicalTrials.gov

Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions
Rheumatoid ArthritisOsteoporosis
Interventions
DRUG

Placebo

Discontinuation of alendronate treatment

DRUG

Alendronate

DRUG

Calcium

Daily dietary supplement of 800mg calcium

DRUG

Vitamin D

Daily dietary supplement of 38 micrograms vitamin D

Trial Locations (6)

5000

Odense University Hospital, Odense

7100

Vejle Hospital, Vejle

8000

Aarhus University Hospital, Aarhus

8600

Silkeborg Regional Hospital, Silkeborg

9000

Aalborg University Hospital, Aalborg

9800

Hjørring Hospital, Hjørring

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT02944799 - Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter